Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Janssen
Janssen
Llama antibodies could provide universal flu protection
BioCentury
Thu, 11/1/18 - 07:16 pm
Janssen
Scripps Research Institute
flu vaccines
Flu
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Forbes
Thu, 11/1/18 - 11:31 am
Janssen
JNJ
Invokana
type 2 diabetes
Arrowhead Pharmaceuticals Closes Agreements with Janssen Worth Up To $3.7 Billion
CP Wire
Wed, 10/31/18 - 11:03 am
Arrowhead Pharmaceuticals
Janssen
JNJ
hepatitis B
Arrowhead Pharmaceuticals Closes Agreements with Janssen Worth Up To $3.7 Billion
Wed, 10/31/18 - 10:25 am
Arrowhead Pharmaceuticals
Janssen
JNJ
Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial
BioSpace
Tue, 10/30/18 - 12:06 pm
JNJ
Janssen
Genmab
Darzalex
clinical trials
Multiple Myeloma
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
CP Wire
Tue, 10/30/18 - 10:22 am
Janssen
JNJ
Symtuza
HIV
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
Tue, 10/30/18 - 09:53 am
Janssen
JNJ
Symtuza
HIV
Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Wed, 10/24/18 - 02:43 pm
Janssen
JNJ
Stelara
Crohn's Disease
clinical trials
J&J snaps up key label expansion for Xarelto
Biopharma Dive
Mon, 10/15/18 - 12:10 pm
JNJ
Xarelto
bloodthinners
Eliquis
Janssen
Bayer
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Market Realist
Thu, 09/13/18 - 11:34 am
JNJ
Janssen
Darzalex
daratumumab
Europe
Multiple Myeloma
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
Mon, 08/20/18 - 11:07 pm
FDA
JNJ
Janssen
Lundbeck
Takeda
major depressive disorder
drug development
Janssen, Bayer to close South Korean plants due to limited demand
Fierce Pharma
Sat, 08/4/18 - 12:12 pm
drug manufacturing
Bayer
Janssen
South Korea
How rival opioid makers sought to cash in on alarm over OxyContin’s dangers
Stat
Thu, 08/2/18 - 11:18 pm
Purdue Pharma
oxycontin
opioids
Janssen
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Wed, 08/1/18 - 11:33 pm
Pfizer
Celltrion
JNJ
Janssen
patents
Remicade
Where does J&J's new drug fit in the crowded HIV market?
Biopharma Dive
Wed, 07/18/18 - 09:54 pm
JNJ
Janssen
FDA
HIV
Symtuza
Johnson & Johnson, looking for its Tremfya niche, starts up new trial program in Crohn's
Fierce Pharma
Wed, 07/11/18 - 11:35 am
JNJ
Tremfya
MorphoSys
Janssen
Crohn's Disease
clinical trials
Microbiome report for week ending 6-24-18
CP Wire
Wed, 06/27/18 - 07:53 pm
Axial Biotherapeutics
Kallyope
Novo Nordisk
CosmosID
microbiome
precisionFDA
Janssen
Microbiotica
Genentech
Microbiome report for week ending 6-24-18
Wed, 06/27/18 - 07:51 pm
Axial Biotherapeutics
Kallyope
Novo Nordisk
CosmosID
microbiome
precisionFDA
Janssen
Microbiotica
Genentech
Danish biotech Genmab hit by ending of trial using key cancer drug
Reuters
Mon, 05/28/18 - 01:35 pm
Genmab
JNJ
Janssen
Darzalex
Janssen drops the BACE as Alzheimer’s candidate joins fail list
Fierce Biotech
Fri, 05/18/18 - 12:09 pm
JNJ
Janssen
BACE inhibitors
atabacestat
Alzheimer's disease
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »